MARCHETTI, Bianca Maria
 Distribuzione geografica
Continente #
NA - Nord America 6.500
AS - Asia 2.244
EU - Europa 2.142
SA - Sud America 558
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 11.645
Nazione #
US - Stati Uniti d'America 6.239
SG - Singapore 1.163
CN - Cina 766
IE - Irlanda 606
UA - Ucraina 597
BR - Brasile 489
IT - Italia 433
CA - Canada 224
RU - Federazione Russa 153
VN - Vietnam 107
SE - Svezia 104
CI - Costa d'Avorio 96
SN - Senegal 63
DE - Germania 57
GB - Regno Unito 51
IN - India 44
KR - Corea 32
AR - Argentina 30
PL - Polonia 26
MX - Messico 20
CH - Svizzera 19
BD - Bangladesh 18
FR - Francia 18
AT - Austria 13
IR - Iran 13
JP - Giappone 13
NL - Olanda 12
GR - Grecia 11
IQ - Iraq 11
UZ - Uzbekistan 11
FI - Finlandia 10
ID - Indonesia 10
CO - Colombia 9
EC - Ecuador 9
ES - Italia 9
PY - Paraguay 9
TR - Turchia 9
ZA - Sudafrica 8
HK - Hong Kong 7
LB - Libano 7
EU - Europa 6
VE - Venezuela 6
BE - Belgio 5
EG - Egitto 5
NG - Nigeria 5
CZ - Repubblica Ceca 4
GT - Guatemala 4
LT - Lituania 4
MA - Marocco 4
PK - Pakistan 4
AU - Australia 3
HN - Honduras 3
IL - Israele 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
BJ - Benin 2
BO - Bolivia 2
CL - Cile 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
CD - Congo 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 11.645
Città #
Dallas 1.029
Santa Clara 829
Jacksonville 728
Dublin 602
Singapore 564
Chandler 547
Houston 406
Boardman 268
Nanjing 171
Lawrence 170
Cambridge 169
Toronto 167
Andover 166
Chicago 166
Catania 127
Ashburn 124
Des Moines 107
Abidjan 96
San Mateo 90
Beijing 81
Wilmington 81
Hefei 73
Los Angeles 73
Dakar 63
Nanchang 62
Shenyang 53
Ottawa 47
Civitanova Marche 46
Hebei 45
Council Bluffs 41
Ho Chi Minh City 36
São Paulo 35
Falls Church 33
Saint Petersburg 32
Seoul 32
Tianjin 31
The Dalles 30
Changsha 28
Jiaxing 27
New York 25
Columbus 24
Hanoi 20
Moscow 20
Seattle 20
Rome 19
Belo Horizonte 16
Grafing 16
Jinan 16
Brooklyn 15
San Francisco 15
Augusta 14
Aversa 14
Norwalk 14
Warsaw 14
Leawood 13
Messina 13
Pune 13
Buffalo 12
London 12
Tappahannock 12
Tokyo 12
Ardabil 11
Kunming 10
Liberty Lake 10
Mascalucia 9
Porto Alegre 9
Ragusa 9
Rio de Janeiro 9
Ann Arbor 8
Denver 8
Frankfurt Am Main 8
Goiânia 8
Hangzhou 8
Milan 8
Stockholm 8
Washington 8
Chennai 7
Curitiba 7
Fortaleza 7
Baghdad 6
Brasília 6
Bremen 6
Florianópolis 6
Haiphong 6
Hong Kong 6
Johannesburg 6
Lappeenranta 6
Munich 6
Redondo Beach 6
Taormina 6
Volta Redonda 6
Ankara 5
Boston 5
Brussels 5
Dhaka 5
Fuzhou 5
Guarulhos 5
Mumbai 5
Passo Fundo 5
Recife 5
Totale 8.093
Nome #
microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches 468
Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease 158
Activation of cytosolic phospholipase A2 and 15-lipoxygenase by oxidized low-density lipoproteins in cultured human lung fibroblasts 129
Extracellular vesicles as nanotherapeutics for Parkinson’s disease 124
Activation of phospholipase A2 and MAP kinases by oxidized low density lipoproteins in immortalized GP8.39 endothelial cells 117
A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus Gland function 111
A Wnt1 regulated Frizzled-1/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection 105
Glia-Derived Extracellular Vesicles in Parkinson's Disease 105
Astrocytes from distinct nigrostriatal brain regions secrete extracellular vesicles able to mediate neuroprotection in cellular models of Parkinson's disease 104
Aging of the reproductive-neuroimmune axis. A crucial role for the hypothalamic neuropeptide luteinizing hormone-releasing hormone 104
High-resolution respirometry reveals mpp+ mitochondrial toxicity mechanism in a cellular model of parkinson’s disease 104
Proteomic profile of extracellular vesicles secreted by astrocytes using high resolution mass spectrometry 102
Vulnerability to Parkinson's Disease: Towards an Unifying Theory of Disease Etiology 100
Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain 99
Ultrastructural and molecular characterization of astrocyte-derived extracellular vesicles from nigrostriatal brain regions: implications for dopaminergic neuroprotection 99
Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3/Akt/Wnt/β-catenin signaling dysregulation 98
Extracellular vesicles as novel diagnostic and prognostic biomarkers for Parkinson’s disease 96
46. Ruolo dei fattori di crescita di origine astrogliale ed esogeni nella migrazione, crescita, differenziazione e controllo funzionale di neuroni ipotalamici immortalizzati LH-RH secernenti. 95
Regulating Wnt signalling, a strategy to prevent neurodegeneration and induce regeneration 92
Beta-adrenergic receptors in the rat mammary gland during pregnancy and lactation: characterization, distribution, and coupling to adenylate cyclase. 91
Mastering the Tools: Natural versus Artificial Vesicles in Nanomedicine 89
Apoptotic cell death and amyloid precursor protein signaling in neuroblastoma SH-SY5Y cells. 87
MAPKs mediate activation of cytosolic phospholipase A2 by amyloid β(25-35) peptide in bovine retina pericytes 87
Phosphatidylserine counteracts physiological and pharmacological suppression of humoral immune response. 86
Basic fibroblast growth factor priming increases the responsiveness of immortalized hypothalamic luteinizing hormone releasing hormone neurones to neurotrophic factors 85
Acute brain ischemia and inflammation: an outcome study 84
Neuroendocrineimmunology (NEI) at the turn of the century: towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology 83
BASIC FIBROBLAST GROWTH FACTOR (bFGF) PRIMING INCREASES THE RESPONSIVENESS OF IMMORTALIZED HYPOTHALAMIC LHRH NEURONS TO NEUROTROPHIC FACTORS 83
Opposite changes of pituitary and ovarian receptors for LHRH in ageing rats: further evidence for a direct neural control of ovarian LHRH receptor activity 82
Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture 82
Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network. 80
Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. 80
Inflammatory biomarkers in blood of patients with acute brain ischemia 80
Upregulation of lymphocyte beta-adrenergic receptor in Down's syndrome: a biological marker of a neuroimmune deficit 79
Involvement of CD45 in dexamethasone- and heat shock-induced apoptosis of rat thymocytes. 79
The MPTP mouse model: Cues on DA release and neural stem cell restorative role 78
ADRENAL-STEROIDS STIMULATE GROWTH AND PROGESTERONE-RECEPTOR LEVELS IN RAT UTERUS AND DMBA-INDUCED MAMMARY-TUMORS 78
BETA-ADRENERGIC RECEPTORS IN DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED MAMMARY-TUMORS IN THE RAT AND THEIR MODULATION BY ESTROGENS 78
Brain endothelial cell-retinal pericyte co-cultures induce cytosolic phospholipase A2 protein expression through activation of PKCa and d isoforms and MAPK/ERK cascade 77
Modulation of glucocorticoid receptor gene expression in the thymus by the sex steroid hormone milieu and correlation with sexual dimorphism of immune response 76
Peptidergic modulation of immune system development: role of luteinizing hormone-releasing hormone. 76
Chemokine-driven molecular cascade orchestrates injury and repair in the MPTP mouse model of basal ganglia injury: The chief instructive role of Writ and concerted glia-neuron cross-talk 76
Beta-adrenergic receptors in DMBA-induced rat mammary tumors: correlation with progesterone receptor and tumor growth. 76
Luteinizing hormone-releasing hormone is a primary signaling molecule in the neuroimmune network 76
Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. 75
Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. 75
Partial blockade of T-cell differentiation during ontogeny and marked alterations of the thymic microenvironment in transgenic mice with impaired glucocorticoid receptor function 74
Chitotriosidase in patients with acute ischemic stroke 73
Modulation of hippocampal LHRH receptors by sex steroids in the rat. 73
Specificity of the direct effect of an LHRH agonist on testicular 17-hydroxylase but not on 5 alpha-reductase activity in hypophysectomized adult rats. 73
Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. 73
Cross-talk communication in the neuroendocrine-reproductive-immune axis. Age-dependent alterations in the common communication networks. 73
Effect of 17-beta estradiol and epidermal growth factor on DNA and RNA labeling in astroglial cells during development, maturation and differentiation in culture 73
Ovarian adrenergic nerves directly participate in the control of luteinizing hormone-releasing hormone and beta-adrenergic receptors during puberty: a biochemical and autoradiographic study. 73
Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease 72
Exposure to a dysfunctional GR from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via NO-induced immunosuppression. J. Immunology 71
Therapeutic perspectives in psychoneuroendocriimmunology (PNEI): potential role of phosphatidylserine in neuroendocrine-immune communications 71
BLOCKADE OF CENTRAL AND PERIPHERAL LUTHEINIZING HORMONE- RELEASING HORMONE (LH-RH) RECEPTORS IN NEONATOL RATS WITH A PATENT LH-RH ANTAGONIST INHIBITS THE MORFOFUNCTIONAL DEVELOPMENT OF THE THYMUS AND MATURATION OF THE CELL-MEDIATED AND HUMORAL IMMUNE RESPONSES 71
The thymus gland as a major target for the central nervous system and the neuroendocrine system: Neuroendocrine modulation of thymic beta(2)-Adrenergic receptor distribution as revealed by in vitro autoradiography. 70
Luteinizing hormone- releasing hormone-binding sites in the rat thymus : characteristics and biological function 70
Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis 70
Lutheinizing hormone-realeasing hormone (LH-RH) agonist restoration of age associated decline of thymus weight, thymic LH-RH receptors, and thymocyte proliferative capacity 69
Unilateral ovariectomy-induced luteinizing hormone-releasing hormone content changes in the two halves of the mediobasal hypothalamus. 69
Impact of gender on longevity?: Estrogens modulation of neuroendocrine-immune axis and their possible role in aging pathologies 68
Wnt your brain be inflamed? Yes, it Wnt! 68
Effect of EGF, IGF-I and insulin on protein labeling in bFGF pretreated or unpretreated nerve cell cultures during LHRH neuron-astrocyte interactions. 68
Multiple sclerosis and anti-Plasmodium falciparum innate immune response 68
Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons induce a functional switch in the growth factor responsiveness of astroglia: involvement of basic fibroblast growth factor 68
GLUCOCORTICOID-CYTOKINE INTERACTIONS - TYPE-II GLUCOCORTICOID RECEPTOR GENE-EXPRESSION IN THE THYMUS IS DOWN-REGULATED BY IMMUNE-SYSTEM ACTIVATION 68
Glucorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide 67
Neuroinfiammazione, NOS inducibile e glucocorticoidi nella programmazione della vulnerabilità al danno neurodegenerativo 67
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 67
The immune response evokes up- and down-modulation of beta 2-adrenergic receptor messenger RNA concentration in the male rat thymus. 66
Steroid hormone modulation of glial inducible nitric oxide synthase orchestrate neuroprotection in experimental parkinsonisin 66
Insulin-like growth factor-I effects on ADP-Ribosylation processes and interactions with glucocorticoids during maturation and differentiation of astroglial cells in primary culture. 66
Neural mechanisms in gonadal and adrenal hyperhophy. 66
A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. 66
I fattori di crescita EGF, IGF-I ed insulina stimolano la sintesi del DNA nelle colture astrogliali e neuronali pretrattate con bFGF. 65
Therapeutic perspectives in psychoneuroendocrinimmunology (PNEI): potential role of phosphatidylserine in neuroendocrine-immune communications. 65
Norepinephrinergic involvement in the neuronal mechanism regulating compensatory ovarian hypertrophy. 65
Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration. 64
Brain dysfunction and the immune system: lymphocyte's beta-adrenergic receptor in Down syndrome. 64
The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions 64
Gender, neuroendocrine-immune interactions and neuron-glial plasticity. Role of luteinizing hormone-releasing hormone (LHRH). 64
Changes in hippocampal LH-RH receptor density during maturation and aging in the rat. 63
Prevention of compensatory ovarian hypertrophy by local treatment of the ovary with 6-OHDA. 63
THE NEUROENDOCRINE-IMMUNE CONNECTIONS IN THE CONTROL OF REPRODUCTIVE FUNCTIONS 63
Tossicità epatica 63
Dissociated changes of pituitary luteinizing hormone-releasing hormone (LHRH) receptors and responsiveness to the neurohormone induced by 17 beta-estradiol and LHRH in vivo in the rat. 63
Further characterization of the direct inhibitory effect of LHRH agonists at the testicular level in the rat. 62
Growth factors released from astroglial cells in primary culture participate in the cross talk between luteinizing hormone-releasing hormone (LHRH) neurons and astrocytes. Effects on LHRH neuronal proliferation and secretion. 62
Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental Parkinsonism: pivotal role for glia-neuron interactions 62
To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? 61
Effetti di fattori di crescita endogeni rilasciati dai medium condizionati astrogliali sulla sintesi del DNA in colture di astrociti pretrattate con fattori di crescita esogeni 61
Signalling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: role of extracellular Ca2+ and L-type Ca2+ channels 61
Parkinson’s disease-associated LRRK2-G2019S mutation disrupts glianeuron crosstalk and impairs dopaminergic neurodevelopment 61
Glia-neuron crosstalk in neuroinflammation, neurodegeneration and neuroprotection 60
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone 60
I fattori di crescita (EGF, bFGF, IGF-I ed INSULINA) Stimolano la sintesi del DNA e dell'RNA nucleare e i processi di ADP-Ribosilazione nelle colture primarie di astrociti. 60
MPTP-reactive “in situ” inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair 60
Totale 8.181
Categoria #
all - tutte 45.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021816 0 0 0 0 269 23 146 6 97 8 225 42
2021/20221.284 161 173 1 31 199 31 190 48 119 2 36 293
2022/20231.884 177 46 28 134 198 356 14 332 508 13 43 35
2023/2024651 63 73 29 46 24 77 23 67 4 15 129 101
2024/20252.910 42 391 178 101 788 272 84 153 231 294 174 202
2025/20262.392 290 241 1.088 386 387 0 0 0 0 0 0 0
Totale 11.878